JPMorgan Chase & Co (JPM) concluded trading on Wednesday at a closing price of $279.25, with 7.0 million shares of worth about $1.96 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 30.51% during that period and on February 19, 2025 the price saw a loss of about -0.25%. Currently the company’s common shares owned by public are about 2.80B shares, out of which, 2.78B shares are available for trading.
Stock saw a price change of 1.55% in past 5 days and over the past one month there was a price change of 7.75%. Year-to-date (YTD), JPM shares are showing a performance of 16.49% which increased to 55.25% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $178.40 but also hit the highest price of $279.97 during that period. The average intraday trading volume for JPMorgan Chase & Co shares is 8.83 million. The stock is currently trading 3.04% above its 20-day simple moving average (SMA20), while that difference is up 9.78% for SMA50 and it goes to 24.98% higher than SMA200.
JPMorgan Chase & Co (NYSE: JPM) currently have 2.80B outstanding shares and institutions hold larger chunk of about 74.22% of that.
The stock has a current market capitalization of $780.81B and its 3Y-monthly beta is at 1.09. PE ratio of stock for trailing 12 months is 14.14, while it has posted earnings per share of $19.75 in the same period. Its PEG reads 2.38 while making debt-to-equity ratio of 2.28. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for JPM, volatility over the week remained 1.17% while standing at 1.49% over the month.
Stock’s fiscal year EPS is expected to rise by 2.21% while it is estimated to increase by 7.59% in next year. EPS is likely to shrink at an annualized rate of 5.94% for next 5-years, compared to annual growth of 12.99% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wolfe Research on January 03, 2025 offering an Outperform rating for the stock and assigned a target price of $269 to it. On November 07, 2024, Robert W. Baird Downgrade their recommendations, while on September 30, 2024, Morgan Stanley Downgrade their ratings for the stock with a price target of $224. Stock get a Hold rating from Deutsche Bank on September 03, 2024.